Back to search

University of Glasgow

A phase 1 trial of the herpes simplex virus HSV1716 in patients with high grade glioma plus an in vitro investigation of the interaction between HSV1716 and ionising radiation

Abstract

dc:description.abstract

HSV1716 is a mutant herpes simplex virus with a deletion in both copies of the RL1 gene, that encodes the protein ICP34.5, a specific determinant of virulence. Section one presents a phase I study in which it has been demonstrated that herpes simplex virus 1716 (HSV1716) does not generate toxicity following injection into brain adjacent to excised high-grade glioma, in patients who proceeded to receive further immunosuppressive radiotherapy or chemotherapy. The survival and imaging data, in addition to the lack of toxicity, were encouraging. Section two investigates the possibility of enhanced cell kill when ionising radiation is employed in conjunction with the ICP34.5 null mutant HSV1716 in a tissue culture model and the possible mechanisms responsible for enhanced cell kill. Using the MTS assay, experiments combining HSV1716 and ionising radiation demonstrated additional cell kill in 373 and MOG cells by day six compared to either modality in isolation. Isobologram analysis confirmed a synergistic relationship between ionising radiation and HSV1716 in 373 cells and an additive relationship in the MOG cell line when the cells were irradiated one hour prior to inoculation. Lastly, stable 3T6 cells expressing ICP34.5 were developed with the aim of elucidating the mechanism of action of the ICP34.5 in the replication cycle of HSV. Functional ICP34.5 and ICP34.5-GFP in the transfected 3T6 cells was detected and able to support the replication of HSV1716. These cells were analysed with respect to HSV1716 infection and were seen to support replication with the appearance of characteristic plaque morphology.

Degree

thesis:*
Level dc:type.qualificationlevel
PhD
Grantor dc:publisher.institution
University of Glasgow
Year dc:date.issued
2006

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Harrow, Stephen

Rights

Language dc:language
en

Chain of custody

source
Harvested from
University of Glasgow
Base URL
theses.gla.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Harrow, Stephen. A phase 1 trial of the herpes simplex virus HSV1716 in patients with high grade glioma plus an in vitro investigation of the interaction between HSV1716 and ionising radiation. PhD thesis, University of Glasgow, 2006.